Report of the Second Meeting of the Member State Mechanism on Substandard/spurious/falsely-labelled/falsified/counterfeit Medical Products. (A/MSM/2/6)
(2013; 11 pages)

Abstract

The second meeting of the Member State Mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products was held on 28 and 29 November 2013 in Geneva.

The Mechanism considered and adopted the non-exhaustive list of actions, activities and behaviours that result in SSFFC medical products, as contained in the report of the Open-ended Working Group to Identify the Actions, Activities and Behaviours that result in SSFFC medical products (see Annex 1). The Mechanism emphasized that the scope of the Member State Mechanism excludes trade and intellectual property considerations, in accordance with paragraph 4 of World Health Assembly resolution WHA65.19.

The Mechanism reviewed the report of the Steering Committee of the Member State Mechanism on SSFFC and adopted the Steering Committee’s suggestions for finalizing the work plan. The work plan is attached, as amended by the Mechanism, in Annex 2...

Related documents
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018